Deutsche Bank
ABBV icon

Deutsche Bank’s AbbVie ABBV Stock Holding History

Deutsche Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,008
Closed -$77K – 4228
2020
Q1 		$77K Sell
1,008
-247
-20% -$21K ﹤0.01% 3353
2019
Q4 		$111K Hold
1,255
– – ﹤0.01% 3534
2019
Q3 		$95K Sell
1,255
-179
-12% -$12.3K ﹤0.01% 3581
2019
Q2 		$104K Buy
1,434
+832
+138% +$65.4K ﹤0.01% 4187
2019
Q1 		$48K Buy
602
+135
+29% +$11K ﹤0.01% 4569
2018
Q4 		$43K Buy
+467
New +$41.1K ﹤0.01% 4532
2018
Q3 		– Sell
-129
Closed -$12K – 5329
2018
Q2 		$12K Sell
129
-40
-24% -$3.91K ﹤0.01% 5113
2018
Q1 		$15K Sell
169
-665
-80% -$73.1K ﹤0.01% 5056
2017
Q4 		$80K Sell
834
-9,339
-92% -$880K ﹤0.01% 4313
2017
Q3 		$903K Buy
10,173
+6,466
+174% +$492K ﹤0.01% 3090
2017
Q2 		$268K Buy
3,707
+2,803
+310% +$188K ﹤0.01% 3776
2017
Q1 		$58K Sell
904
-204
-18% -$12.8K ﹤0.01% 4163
2016
Q4 		$69K Buy
1,108
+681
+159% +$41.6K ﹤0.01% 4237
2016
Q3 		$26K Sell
427
-601
-58% -$38.9K ﹤0.01% 4452
2016
Q2 		$63K Buy
1,028
+358
+53% +$21.8K ﹤0.01% 4308
2016
Q1 		$38K Sell
670
-1,266
-65% -$70.6K ﹤0.01% 4414
2015
Q4 		$114K Sell
1,936
-10,360
-84% -$597K ﹤0.01% 4001
2015
Q3 		$668K Buy
12,296
+7,837
+176% +$510K ﹤0.01% 3191
2015
Q2 		$299K Buy
4,459
+821
+23% +$53.6K ﹤0.01% 3673
2015
Q1 		$212K Buy
3,638
+1,788
+97% +$108K ﹤0.01% 3752
2014
Q4 		$121K Buy
+1,850
New +$117K ﹤0.01% 4595
2014
Q1 		– Sell
-820
Closed -$4K – 5571
2013
Q4 		$4K Buy
820
+70
+9% +$3.44K ﹤0.01% 5050
2013
Q3 		$1K Hold
750
– – ﹤0.01% 5369
2013
Q2 		$1K Buy
+750
New +$32.8K ﹤0.01% 5222

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank's ABBV Position: Q1 2026 in Review

Deutsche Bank reduced its AbbVie (ABBV) stake by 5.9% in Q1 2026, selling an estimated $133M and leaving 9,531,362 shares worth $2.07B. The position accounts for 0.68% of the portfolio, ranked #19.

Deutsche Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.31B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Deutsche Bank held 9,531,362 shares of AbbVie worth $2.07B as of Q1 2026.
  • Deutsche Bank sold 598,352 AbbVie shares in Q1 2026, an estimated $133M.
  • AbbVie made up 0.68% of Deutsche Bank's portfolio in Q1 2026, its #19 holding.
  • Deutsche Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's AbbVie position peaked at $2.31B in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.